Yanti Khusmiran

Yanti Khusmiran is a specialist at Cellular Institute, where she serves as Director of the ISSCA Asia Chapter and an advisory-board figure for immunology and regenerative medicine. Her profile describes over two decades of pioneering regenerative and aesthetic medicine across Asia, paired with leadership in clinical education. She is credited with building Indonesia’s stem cell and aesthetic clinic network with 6+ branches across Surabaya, Jakarta, Bandung, and Bali. In 2023, she launched Natural Killer (NK) Cell therapy in Indonesia, described as the first in Asia to offer the treatment at international GSCG/ISSCA-certified standards.

Education

• Graduate — Universitas Wijaya Kusuma (Surabaya).

Work experience

• Director — ISSCA Asia Chapter (International Society for Stem Cell Application) — Cellular Institute.
• Advisory Board member — Cellular Institute.
• Founder — Indonesia’s GSCG-certified stem cell network.

Clinical focus and techniques

At Cellular Institute, Yanti Khusmiran’s profile places her work within stem cell therapy, regenerative medicine, and regenerative aesthetics. Her clinic activity includes mesenchymal stem cell protocols, NK Cell therapy, and exosome therapy, along with training and standards for cellular immunotherapy delivery.

• Mesenchymal stem cell protocols for regeneration, anti-aging, immune modulation, and chronic disease management.
• Natural Killer (NK) Cell therapy (NK cell immunotherapy).
• Exosome therapy.

Professional societies and certifications

• International Society for Stem Cell Application (ISSCA) — ISSCA Asia Chapter (Director).
• GSCG/ISSCA-certified training center — Jakarta (as described).
• GSCG-certified stem cell network (as described).
• GSCG/ISSCA-certified standards for NK Cell therapy (as described).

Courses and advanced training

• Jakarta clinic described as a GSCG/ISSCA-certified training center educating physicians on stem cell protocols, NK Cell therapy, and regenerative medicine standards.

Cellular Institute’s international program supports discovery calls and physician evaluation before regenerative therapy planning. Yanti Khusmiran’s profile emphasizes that advanced cellular immunotherapy and regenerative protocols are delivered through certified standards, including the 2023 NK Cell therapy launch in Indonesia.